CINECA IRIS Institutional Research Information System

MORNESE PINNA, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.454
EU - Europa 1.085
AS - Asia 635
SA - Sud America 403
AF - Africa 53
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.382
IT - Italia 407
CN - Cina 216
PE - Perù 193
IE - Irlanda 105
FR - Francia 99
SE - Svezia 88
TR - Turchia 87
SG - Singapore 84
AR - Argentina 83
ES - Italia 82
CL - Cile 69
DE - Germania 66
AT - Austria 49
MX - Messico 47
GB - Regno Unito 38
IN - India 33
VN - Vietnam 33
ID - Indonesia 30
BE - Belgio 26
JP - Giappone 24
BR - Brasile 23
CA - Canada 21
AU - Australia 20
IR - Iran 20
RO - Romania 19
NL - Olanda 17
BO - Bolivia 16
SA - Arabia Saudita 16
HK - Hong Kong 14
FI - Finlandia 13
JO - Giordania 13
MA - Marocco 13
ZA - Sudafrica 13
CO - Colombia 12
UA - Ucraina 12
RU - Federazione Russa 11
TN - Tunisia 11
PL - Polonia 10
GR - Grecia 9
CZ - Repubblica Ceca 8
LB - Libano 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
KZ - Kazakistan 7
TH - Thailandia 7
CH - Svizzera 6
KR - Corea 6
EG - Egitto 5
SY - Repubblica araba siriana 5
UG - Uganda 5
EU - Europa 4
HR - Croazia 4
SI - Slovenia 4
CR - Costa Rica 3
MD - Moldavia 3
MN - Mongolia 3
PY - Paraguay 3
BG - Bulgaria 2
DK - Danimarca 2
EC - Ecuador 2
NG - Nigeria 2
PS - Palestinian Territory 2
TG - Togo 2
TW - Taiwan 2
UY - Uruguay 2
AN - Antille olandesi 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
IQ - Iraq 1
LI - Liechtenstein 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
SN - Senegal 1
Totale 3.654
Salva come PNG Salva come JPEG
Città #
Chandler 293
Lima 131
Dublin 104
Fairfield 79
Torino 69
Singapore 66
Beijing 64
Ashburn 60
Woodbridge 54
Ann Arbor 50
Nyköping 50
Turin 46
Houston 42
Vienna 40
Wilmington 39
Milan 38
Santiago 36
Medford 31
Dearborn 30
Princeton 26
Redwood City 26
New York 25
Cambridge 24
Jakarta 24
Paris 24
Villeurbanne 23
Istanbul 22
Ankara 17
Brussels 17
San Miguel de Tucumán 17
Guangzhou 16
Seattle 16
Huancayo 15
Madrid 15
Barcelona 14
Arequipa 13
Bucharest 13
Buenos Aires 13
Federal 13
Pisa 12
Dong Ket 11
La Paz 11
Mexico City 11
Boardman 10
Chengdu 10
Rome 10
San Diego 10
Santa Clara 10
Fremont 9
Hangzhou 9
Hebei 9
Jacksonville 9
Konya 8
Omaha 8
Riyadh 8
Warsaw 8
Brno 7
Delhi 7
Helsinki 7
Naples 7
Osorno 7
Padova 7
Pavia 7
Angers 6
Bari 6
Buffalo 6
Cape Town 6
Heverlee 6
Hong Kong 6
Innsbruck 6
Kansas City 6
Lima region 6
Nanjing 6
Pozzolo Formigaro 6
Shanghai 6
Tashkent 6
Toronto 6
Trujillo 6
Upper Marlboro 6
Bogotá 5
Boston 5
Córdoba 5
Nagoya 5
Norwalk 5
Porto Alegre 5
Stuttgart 5
Valencia 5
Vigevano 5
Washington 5
Amman 4
Astana 4
Bariloche 4
Bengaluru 4
Berlin 4
Chicago 4
Concorezzo 4
Cúcuta 4
Dammam 4
Edinburgh 4
Gothenburg 4
Totale 2.097
Salva come PNG Salva come JPEG
Nome #
Pulmonary Echinococcosis or Lung Hydatidosis: A Narrative Review 1.290
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients 342
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship 170
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy? 145
V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosis 134
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients 125
Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study 107
Role of simeprevir plasma concentrations in HCV treated patients with dermatological symptoms 95
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge 94
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs 90
Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia 78
Real life Study on the Pharmacokinetic of Remdesivir in ICU patients admitted for Severe COVID-19 Pneumonia 76
Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry 73
Daclatasvir Plasma Levels in a Cohort of Patients with Hepatitis C Virus Infection Taking Methadone: A Prospective Analysis 68
Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study 66
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy 66
Antibiotic de-escalation experience in the setting of emergency department: A retrospective, observational study 66
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients 63
New cephalosporins for the treatment of pneumonia in internal medicine wards 60
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 56
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study 56
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: a prospective study 53
Impact of an empiric antimicrobial therapy manual on antimicrobial usage and multidrug resistant organism trends in a large Italian teaching hospital 51
Retreatment with sofosbuvir/velpatasvir in cirrhotic patients with genotype-4 who failed a previous interferon-free regimen: A case series 51
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy 49
JC virus DNA in cerebrospinal fluid: insight into clinical significance 43
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens 42
Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key? 33
Meropenem/Vaborbactam and Cefiderocol as Combination or Monotherapy to Treat Multi-Drug Resistant Gram-Negative Infections: A Regional Cross-Sectional Survey from Piedmont Infectious Disease Unit Network (PIDUN) 29
Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series 20
Epidemiology and Risk Factors for Nosocomial Infections in Left Ventricular Assist Device Recipients 17
Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality 16
Nodular Cutaneous Lesions in Immune-Compromised Hosts as a Clue for the Diagnosis of Disseminated Nocardiosis: From Bedside to Microbiological Identification 14
Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: a two-year single-centre experience 9
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic 8
The Diagnostic Relevance of β-D-Glucan for Candidemia within Internal Medicine Wards 7
Beta Lactams Plus Daptomycin Combination Therapy for Infective Endocarditis: An Italian National Survey (BADAS) 6
Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient 6
Predictors of mortality in patients with COVID-19 infection in different health-care settings: A retrospective analysis from a CORACLE study group 5
null 2
Real-Life Experience of Molnupiravir in Hospitalized Patients Who Developed SARS-CoV2-Infection: Preliminary Results from CORACLE Registry 2
Totale 3.783
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.207
article - articoli 0
book - libri 0
conference - conferenze 319
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.526
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020230 0 0 3 27 9 45 19 11 15 82 10 9
2020/2021216 6 12 10 6 11 20 2 8 8 39 33 61
2021/2022584 35 44 34 33 36 54 43 20 39 57 105 84
2022/20231.166 74 70 50 108 93 199 61 118 128 61 119 85
2023/2024896 99 110 47 51 98 92 61 72 21 97 81 67
2024/2025226 51 81 94 0 0 0 0 0 0 0 0 0
Totale 3.783